Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesPreferred Dividend PaymentsProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Fortress Biotech (FBIO) Revenue (2016 - 2025)

Fortress Biotech has reported Revenue over the past 12 years, most recently at $18.1 million for Q4 2025.

  • Quarterly results put Revenue at $18.1 million for Q4 2025, up 43.8% from a year ago — trailing twelve months through Dec 2025 was $65.3 million (up 18.39% YoY), and the annual figure for FY2025 was $63.3 million, up 14.74%.
  • Revenue for Q4 2025 was $18.1 million at Fortress Biotech, up from $17.6 million in the prior quarter.
  • Over the last five years, Revenue for FBIO hit a ceiling of $40.1 million in Q4 2023 and a floor of $182000.0 in Q3 2023.
  • Median Revenue over the past 5 years was $14.8 million (2024), compared with a mean of $13.9 million.
  • Peak annual rise in Revenue hit 10918.68% in 2023, while the deepest fall reached 98.9% in 2023.
  • Fortress Biotech's Revenue stood at $17.5 million in 2021, then crashed by 97.92% to $364000.0 in 2022, then surged by 10918.68% to $40.1 million in 2023, then crashed by 68.64% to $12.6 million in 2024, then soared by 43.8% to $18.1 million in 2025.
  • The last three reported values for Revenue were $18.1 million (Q4 2025), $17.6 million (Q3 2025), and $16.4 million (Q2 2025) per Business Quant data.